12.11.2014 Views

CLINICAL PROTOCOL - Halton and St Helens PCT

CLINICAL PROTOCOL - Halton and St Helens PCT

CLINICAL PROTOCOL - Halton and St Helens PCT

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>CLINICAL</strong> <strong>PROTOCOL</strong><br />

For use in:<br />

Target Audience:<br />

Purpose<br />

Document Author:<br />

Approved by:<br />

Ratified by:<br />

Policy Index No:<br />

<strong>St</strong>erile Instrument Pack Protocol<br />

Version Number: 1.0<br />

<strong>PCT</strong>-wide<br />

All Trust Podiatry <strong>St</strong>aff<br />

To set the st<strong>and</strong>ard for use <strong>and</strong> h<strong>and</strong>ling of<br />

sterile reusable instrument packs used by the<br />

<strong>Halton</strong> Podiatry Service<br />

Julie Griffiths<br />

Clinical Polices Guidelines Group or Equivalent<br />

Policy Sub-Committee (PSC)<br />

H<strong>St</strong>HCL223<br />

Effective From: December 2009<br />

Review Date: December 2012<br />

<strong>St</strong>atutory <strong>and</strong> legal requirements<br />

Implementation Lead<br />

Implementation Process<br />

<strong>St</strong><strong>and</strong>ards for Better Health/Code of Practice<br />

for the Prevention <strong>and</strong> Control of Health Care<br />

Associated Infections. Protocol based on<br />

recommendations from the NHS Litigation<br />

Authority<br />

Head of Podiatry<br />

Refer to attached dissemination plan<br />

The Trust is committed to creating an environment that promotes equality <strong>and</strong> embraces<br />

diversity, both within our workforce <strong>and</strong> in service delivery. This document should be<br />

implemented with due regard to this commitment<br />

This document seeks to uphold the duties <strong>and</strong> principles contained within the Human Rights<br />

Act. All <strong>St</strong>aff within the <strong>PCT</strong> should be aware of its implications<br />

This protocol is due for review by December 2012. After this date, this protocol <strong>and</strong> associated<br />

process documents may become invalid. All users should ensure that they are consulting the<br />

current version of this document.<br />

Page 1 of 15


Key individuals involved in developing the document (Internal <strong>St</strong>aff Only)<br />

Name(s)<br />

Designation<br />

Julie Griffiths<br />

Andrew Lythgoe<br />

Podiatry Manager<br />

Podiatry Team Leader<br />

Distributed to the following for approvals <strong>and</strong> comments<br />

Committee(s)<br />

Members of the Policy Sub Committee (PSC)<br />

Members of the Clinical Policies Guidelines<br />

Group (CPG)<br />

All Members of <strong>Halton</strong> Podiatry Team<br />

Page 2 of 15


Table of Contents<br />

Rationale......................................................................................................................................4<br />

Protocol <strong>St</strong>eps..............................................................................................................................5<br />

References.................................................................................................................................10<br />

Appendix 1 .................................................................................................................................11<br />

Appendix 2 .................................................................................................................................12<br />

Appendix 3 .................................................................................................................................13<br />

Appendix 4 .................................................................................................................................14<br />

Page 3 of 15


RATIONALE<br />

The rationale of this protocol is to document the Podiatry department’s procedure for the<br />

h<strong>and</strong>ling of podiatry instruments to ensure that all reasonable steps are taken to reduce the risk<br />

of cross infection during podiatry treatment through contact with podiatry instruments.<br />

This protocol should be read in conjunction with the Trust’s Policy Prevention <strong>and</strong> Management<br />

of Occupational Health Exposure to BBV <strong>and</strong> Prevention of Sharps Injuries, on the Document<br />

Portal, <strong>and</strong> Infection Prevention <strong>and</strong> Control Policy No.27 Aseptic Technique<br />

The Podiatry Department uses both reusable <strong>and</strong> disposable instruments in order to carry out<br />

podiatry treatments.<br />

The Countess of Chester Hospital (COCH) decontaminates the department’s reusable<br />

instruments to the st<strong>and</strong>ard HTM2010.<br />

Decontaminated reusable instruments are supplied as sets of multiple instruments <strong>and</strong> single<br />

instruments (Refer to Appendix 1) in sterile packaging.<br />

Disposable instruments are supplied as individual instruments in sterile packaging.<br />

The majority of podiatry treatments will be undertaken using a basic pack of reusable<br />

instruments. However at times it will be clinically appropriate to supplement these packs from<br />

the range of single wrapped reusable <strong>and</strong> disposable instruments.<br />

For nail surgery <strong>and</strong> local anaesthetic procedures separate packs are available.<br />

All podiatry treatments must be carried out using authorised podiatry instruments as supplied in<br />

their sterile state.<br />

No other instrumentation may be used than those authorised <strong>and</strong> supplied by the department.<br />

It is each individual staff member’s responsibility to ensure that they fully follow this protocol.<br />

All new podiatry staff as part of their induction will be given training on this protocol.<br />

Page 4 of 15


<strong>PROTOCOL</strong> STEPS<br />

<strong>St</strong>eps<br />

1. <strong>St</strong>orage of instruments<br />

Reusable instruments are transported to <strong>and</strong> from COCH in bespoke (Blue) transportation<br />

boxes.<br />

Fast transport will deliver processed clean instruments <strong>and</strong> remove dirty instruments from<br />

each podiatry site, on a 48 hour turnaround.<br />

Clean instruments must be stored separately from dirty instruments. Areas have been<br />

designated for the segregated storage of clean <strong>and</strong> dirty instruments at each podiatry site<br />

Clean disposable instruments, must be stored in the designated clean areas.<br />

Podiatry staff whilst undertaking domiciliary visits should store clean <strong>and</strong> dirty instrument<br />

sets separately. A carried bag inside a second carry bag is sufficient to keep dirty<br />

instrument sets separate from the podiatrist’s / podiatry assistants visiting bag <strong>and</strong> clean<br />

instrument sets.<br />

2. Checking Supplies<br />

The Black tie should be removed with a pair of scissors. Podiatry staff should then check<br />

the boxes’ contents against the delivery note, which is inside each box of clean<br />

instruments.<br />

If there are any discrepancies between the delivery note <strong>and</strong> the box contents, these<br />

should be noted on the delivery note, the note then photocopied prior to storing it in the<br />

file. The photocopy of the delivery note should then be forwarded to the line manager for<br />

monitoring.<br />

Clean packs of instruments should be transferred to the treatment area as required.<br />

3. Use of Instruments<br />

Examining the Packaging<br />

Reusable instruments<br />

The podiatrist / podiatry assistant should ensure that they select the appropriate<br />

instrumentation prior to commencing treatment. The packaging should be examined to<br />

ensure that it is intact.<br />

Any instruments sets with damaged packaging must not be used. The contents list should<br />

be removed from the packaging <strong>and</strong> note made to describe the way in which the<br />

packaging is damaged. The contents list should be signed <strong>and</strong> returned to the packaging.<br />

The set should then be returned to the processing company as a dirty set<br />

Page 5 of 15


Disposable instruments<br />

The podiatrist / podiatry assistant should ensure that they select the appropriate<br />

instrumentation prior to commencing treatment. The packaging should be examined to<br />

ensure that it is intact.<br />

Any instruments with damaged packaging must not be used.<br />

The instrument should be disposed of in the instrument sharps bin.<br />

The packaging should be disposed of in the domestic waste.<br />

Prior to treatment<br />

The instruments / sets should be placed in the treatment field.<br />

The podiatrist / podiatry assistant will then open the sterile packaging.<br />

H<strong>and</strong>s then must be washed, prior to treating the patient, before the contents of the pack<br />

are removed.<br />

The podiatrist / podiatry assistant will then visually check the packs contents against the<br />

content list to establish if the all instrumentation is as stated.<br />

If any instruments are missing the podiatrist / podiatry assistant will make a clinical<br />

decision as to whether there are sufficient instruments to undertake the treatment<br />

required.<br />

If it is decided that the pack contents are insufficient, the contents list should be removed<br />

from the packaging <strong>and</strong> note made as to which instruments are missing. The contents list<br />

should be signed <strong>and</strong> returned to the packaging.<br />

The set should then be returned to COCH as a dirty set<br />

The podiatrist / podiatry assistant will then repeat the procedure with a new set.<br />

Following treatment<br />

After washing their h<strong>and</strong>s the podiatrist/ podiatry assistant should apply one of the<br />

barcode stickers from the reusable instrument set after completing the patient’s notes <strong>and</strong><br />

before signing the record. If more that one set of reusable instruments or single wrapped<br />

reusable instruments have been used then a sticker from each individual pack must be<br />

applied. The second barcode should be stuck to the day sheet next to the patient<br />

undergoing the treatment<br />

Page 6 of 15


Disposable instruments do not have tracking barcodes as they are disposed of after use.<br />

The podiatrist / podiatry technician, should then tick the content list on the pre op<br />

box to confirm that all instruments were present, <strong>and</strong> sign to say that all the<br />

instruments are being returned <strong>and</strong> that all scalpel blades have been removed on<br />

the separate section.<br />

Lubrication of nipper hinges using dental aerosol lubrication is at the discretion of<br />

practitioner.<br />

The instruments <strong>and</strong> tray must be placed in the supplied return bag. Podiatry staff should<br />

not undertake any pre cleaning of instruments.<br />

The content list should then be placed in the return bag.<br />

The return bag should be securely folded over <strong>and</strong> placed in a transit box. Note this<br />

transit box must only be used for dirty instruments.<br />

Once the transit box is full to the acceptable level (no more than 25 sets), the box should<br />

be closed <strong>and</strong> secured with another black tag, the box should then be transferred to the<br />

dirty instrument storage area.<br />

The sterile field <strong>and</strong> outside bag should be placed in the domestic waste.<br />

4. Quality Issues<br />

Reusable instruments<br />

Quality issues fall into 2 categories.<br />

1. Problems with the quality of the instrument – e.g. it is broken; nail nippers stiff,<br />

broken springs, cutting edge may become worn, shaft of bur bent. These may be<br />

identified on opening a pack. However in many cases it is not until the instrument<br />

is used the problem is identified. The podiatrist / podiatry assistant should<br />

document on the contents list a description of the problem <strong>and</strong> any action required<br />

to remedy, e.g. replacement. Lubrication of nipper hinges using dental aerosol<br />

lubrication is at the discretion of practitioner.<br />

The podiatrist / podiatry assistant will make a clinical decision to determine if the<br />

remaining instruments are sufficient to continue treatment. If not then a new pack<br />

should be opened.<br />

2. Quality issues with the decontamination process e.g. dirty, foreign body present,<br />

adhesive from podiatry products present. No part of the instrument pack must be<br />

used under any circumstances. The pack should be isolated <strong>and</strong> not returned to<br />

Page 7 of 15


processing company until this has been reported to <strong>and</strong> return authorised by the<br />

line manager. The manager will complete the incident reporting.<br />

Disposable instruments<br />

If the quality of the instrument as supplied is a cause for concern the product log number<br />

should be recorded. If the instrument has not been used then it should be kept for<br />

inspection by the line manager, if the instrument has been used then the instrument must<br />

be disposed of <strong>and</strong> the product log number <strong>and</strong> a description of the fault should be<br />

reported to the line manager.<br />

5. Scalpel Blades<br />

Podiatry scalpel h<strong>and</strong>les are supplied as reusable instruments in the basic sets.<br />

There is one scalpel in each basic set.<br />

If multiple blades are required for one treatment, that have not come into contact with<br />

body fluids (blood, pus), then the podiatrist should change the blade using a single use<br />

surgical blade remover this should then be immediately disposed of in the sharps bin.<br />

The podiatrist can then continue to use the scalpel with the new blade.<br />

For treatments in clinic, once the treatment is complete then the blade should be removed<br />

using a sharps bin with an integral blade remover (as this is the most cost effective<br />

method).<br />

For treatments in patient’s own homes, hospitals etc all blades must be removed using a<br />

single use surgical blade remover this should then be immediately disposed of in the<br />

sharps bin.<br />

If the scalpel blade has been in contact body fluids e.g. blood, pus or used for wound<br />

debridement. The blade must be immediately removed using a sharps bin with an integral<br />

blade remover if in clinic or with a single use surgical blade remover if this type of sharps<br />

bin is not available.<br />

The podiatrist must not continue to use this h<strong>and</strong>le; it should be isolated with its set of<br />

instruments <strong>and</strong> returned as dirty instruments.<br />

If a scalpel is required to continue treatment a new instrument set must be used.<br />

It is the podiatrist’s responsibility to check scalpel h<strong>and</strong>les prior to returning<br />

instrument sets to the processing company to ensure that no blades are left on the<br />

h<strong>and</strong>les. When initialling the contents list prior to the sets return the podiatrist is<br />

verifying that all blades are removed. This process will be monitored via returns<br />

from COCH; repeated breaches, following incident reports will be dealt with under<br />

the Trust’s Disciplinary Procedure.<br />

Page 8 of 15


6. Instruments Contaminated with Body Fluid<br />

Reusable instruments e.g. nail nippers, which are contaminated with body fluid during<br />

treatments must be immediately isolated from the set being used. If the type of<br />

instrument, which was contaminated, is not required to complete the treatment then the<br />

remaining instruments in the set may continue to be used.<br />

If the type of instrument, which was contaminated, is required then a new set of<br />

instruments must be used.<br />

Disposable instruments e.g. nail files, which are contaminated with body fluid during<br />

treatments must be immediately disposed of in clinical waste.<br />

7. Disposable Nail Files<br />

Disposable nail files are routinely used for treatments. If following treatment the file is in<br />

good order <strong>and</strong> has not been in contact with any body fluid or mycotic infection, this can<br />

be offered to the individual patient, to support their self-care.<br />

Nail files which have not been contaminated with body fluids <strong>and</strong> which are not given to<br />

individual patients following treatment should be disposed of in domestic waste.<br />

Nail files which have been contaminated with body fluids should be disposed of in clinical<br />

waste.<br />

8. Packs Returned from (COCH) with Scalpel Blades in Place.<br />

(COCH) are not responsible for removing any scalpel blades returned on h<strong>and</strong>les. They<br />

may return the pack in a separate transit box, which is clearly identifiable as a hazard.<br />

It is the responsibility of the podiatry department to remove such blades. Only podiatrist<br />

should remove these blades.<br />

The pack should be placed on a flat surface. A pair of scissors should be used to cut the<br />

bag at the top to expose the contents. Once the scalpel h<strong>and</strong>le is fully visible, the<br />

podiatrist may then pick it up <strong>and</strong> remove the blade with using a sharps bin with an<br />

integral blade remover.<br />

The set of instruments must then be returned as a dirty set.<br />

Page 9 of 15


REFERENCES<br />

Reference<br />

DH, Code of Practice for the Prevention<br />

<strong>and</strong> Control of Healthcare associated<br />

Infection (2008)<br />

National Institute for Clinical Excellence<br />

(2003) Clinical Guideline-Infection Control<br />

Relevance (whole document<br />

or section, please state)<br />

Whole<br />

Whole<br />

Evidence<br />

Grade<br />

Code of<br />

Practice<br />

Nice Guideline<br />

Page 10 of 15


APPENDIX 1<br />

Nail Surgery Pack:-<br />

Scalpel h<strong>and</strong>le No 3<br />

Dressing scissors<br />

Dental syringe<br />

Dental syringe (black plastic)<br />

Lock elevator<br />

Elevator small<br />

Beaver blade h<strong>and</strong>le<br />

Tube gauze applicator small<br />

Tube gauze applicator large<br />

Blacks file<br />

Mosquito forceps fine<br />

Mosquito forceps med<br />

Mosquito forceps wide<br />

Thwaites nippers<br />

Tourniquet blue / green / orange<br />

Dressing Pack:-<br />

Scalpel h<strong>and</strong>le No 3<br />

Dressing scissors<br />

Mosquito forceps fine<br />

Routine Treatment Pack:-<br />

Scalpel h<strong>and</strong>le No 3<br />

Dressing scissors<br />

Blacks file<br />

Diamond file<br />

Nail nippers<br />

Single Instrument Pack:-<br />

Scalpel h<strong>and</strong>le No 3<br />

In growing toe nail nippers<br />

Extra fine blacks file<br />

Beaver blade h<strong>and</strong>le<br />

Diamond burr<br />

Tube gauze applicator small<br />

Tube gauze applicator large<br />

Page 11 of 15


APPENDIX 2<br />

EQUALITY IMPACT ASSESSMENT TOOL<br />

To be completed with the corporate document when submitted to the appropriate committee for<br />

consideration, approval <strong>and</strong> ratification.<br />

1. Does the corporate document affect one group<br />

less or more favourably than another on the basis<br />

of:<br />

Race no<br />

Ethnic origins (including gypsies <strong>and</strong> travellers) no<br />

Nationality no<br />

Gender no<br />

Culture no<br />

Religion or belief no<br />

<br />

Sexual orientation including lesbian, gay <strong>and</strong><br />

bisexual people<br />

Age no<br />

<br />

Disability - learning disabilities, physical disability,<br />

sensory impairment <strong>and</strong> mental health problems<br />

2. Is there any evidence that some groups are<br />

affected differently?<br />

3. If you have identified potential discrimination, are<br />

there any exceptions valid, legal <strong>and</strong>/or<br />

justifiable?<br />

4. Is the impact of the policy/guidance likely to be<br />

negative?<br />

5. If so can the impact be avoided? n/a<br />

6. What alternatives are there to achieving the<br />

policy/guidance without the impact?<br />

7. Can we reduce the impact by taking different<br />

action?<br />

no<br />

no<br />

no<br />

n/a<br />

no<br />

n/a<br />

n/a<br />

Comments<br />

If you have identified a potential discriminatory impact of this corporate document, please refer it<br />

to [insert name of appropriate person], together with any suggestions as to the action required<br />

to avoid/reduce this impact.<br />

For advice in respect of answering the above questions, please contact [insert name of<br />

appropriate person <strong>and</strong> contact details].<br />

Page 12 of 15


APPENDIX 3<br />

DISSEMINATION AND TRAINING PLAN<br />

To be completed with the corporate document when submitted to the appropriate committee for<br />

consideration, approval <strong>and</strong> ratification.<br />

The status column must be given a Red, Amber or Green rating with evidence to demonstrate<br />

an action has been completed.<br />

DISSEMINATION PLAN<br />

Title of document: Policy on development<br />

of corporate documents<br />

Date finalised: December 2009<br />

Dissemination Lead: (Print name <strong>and</strong><br />

contact details) Linda Spooner<br />

Previous document already being used?<br />

No<br />

Proposed action to retrieve out-of-date<br />

copies of the document:<br />

To be disseminated to:<br />

Trust Times<br />

Team Brief<br />

Training sessions (Give Details Below)<br />

Other (Give Details Below) √<br />

IMPLEMENTATION PLAN<br />

N/A<br />

Disseminated<br />

by whom?<br />

Team<br />

Leaders<br />

Timescale<br />

(Date)<br />

<strong>St</strong>atus<br />

R A G<br />

G<br />

Paper<br />

or<br />

Electronic<br />

Comments<br />

Training Timescale Owner <strong>St</strong>atus<br />

R A G<br />

Training Event <strong>St</strong>aff monthly Briefing Feb 2010 Julie<br />

Griffiths<br />

Training Plan Lead Julie Griffiths<br />

Compliance Monitoring Timescale Owner <strong>St</strong>atus<br />

R A G<br />

<br />

<br />

<br />

<br />

Methodology to be used for monitoring/audit (please include <strong>PCT</strong><br />

Audit Proposal Form)<br />

Responsibilities for conducting monitoring/audit<br />

Frequency of monitoring/audit (e.g. annually, 6 monthly etc)<br />

Process for reviewing/reporting results<br />

G<br />

Denotes: Action not yet taken or deadline for action not met. Action plan to address this must be provided.<br />

Denotes: Action partially implemented.<br />

Denotes: Action complete.<br />

Page 13 of 15


APPENDIX 4<br />

CHECKLIST FOR THE REVIEW AND APPROVAL OF ALL CORPORATE<br />

DOCUMENTS<br />

Name of Document: Policy on the Development of Corporate Policies<br />

Name of Author: Nikki Hotchin<br />

To be completed by the author, signed <strong>and</strong> attached to all corporate documents which guide practice when<br />

submitted to the Policy Sub-Committee for consideration <strong>and</strong> approval.<br />

Please consider the checklist when developing any corporate document. All items under section 1 must be<br />

answered “YES” before submitting to the approving committee <strong>and</strong> ratification by the Policy Sub-Committee.<br />

Checklist<br />

Yes/No/<br />

Unsure<br />

(Author to<br />

complete)<br />

Yes/No/<br />

Unsure<br />

(Committee<br />

Use Only)<br />

Committee Use<br />

Only<br />

1. Minimum Requirements<br />

Does it have the completed approved checklist<br />

attached?<br />

Yes<br />

Does the title properly describe the document? Is it<br />

clear the document is a policy, procedure, clinical<br />

guideline, SOP or protocol?<br />

Yes<br />

Is a completed dissemination <strong>and</strong> implementation<br />

plan attached, including the necessary<br />

training/support detailing who will be responsible for<br />

co-ordinating the plan?<br />

Yes<br />

Does the document include a completed Equality<br />

<strong>and</strong> Diversity Plan?<br />

Yes<br />

Is there a plan to review or audit compliance with<br />

the document?<br />

2. Rationale<br />

Are reasons for the development of the document<br />

stated?<br />

Yes<br />

3. Development Process<br />

Are the purpose, aims, objectives <strong>and</strong> outcomes of<br />

the document clear?<br />

Yes<br />

Is the target audience clear?<br />

Yes<br />

Are individuals/stakeholder/users with relevant<br />

expertise involved or consulted in the development<br />

of the document, identified <strong>and</strong> listed on the<br />

contribution list?<br />

Yes<br />

Has the document been developed using the<br />

corporate template including style <strong>and</strong> format?<br />

Yes<br />

Are the appropriate definitions <strong>and</strong> glossary of terms<br />

listed? (If applicable)<br />

Yes<br />

4. Content<br />

Is it clear that the policy neither duplicates nor<br />

Yes<br />

Page 14 of 15


Checklist<br />

conflicts with other corporate documents?<br />

Yes/No/<br />

Unsure<br />

(Author to<br />

complete)<br />

Yes/No/<br />

Unsure<br />

(Committee<br />

Use Only)<br />

Committee Use<br />

Only<br />

Does the document contain an approved Care<br />

Pathway?<br />

N/A<br />

Has an Equality Impact Assessment been carried<br />

out?<br />

Yes<br />

Has a Human Rights Impact Assessment been<br />

carried out?<br />

No<br />

5. References <strong>and</strong> Evidence Base<br />

Is the type of evidence required to support the<br />

document identified explicitly i.e. referencing <strong>and</strong><br />

grading evidence including local corporate<br />

documents.<br />

Yes<br />

Are key references cited?<br />

Yes<br />

6. Approval<br />

Does the document identify which<br />

committee/group/work stream will approve it?<br />

Yes<br />

Have the joint Human Resources/staff side<br />

committee (or equivalent) approved the document?<br />

Where applicable<br />

N/A<br />

7. NHS Constitution<br />

Has due regard been paid to the NHS Constitution<br />

which outlines what <strong>St</strong>aff, Patients <strong>and</strong> the Public<br />

can expect from the NHS, along with what the NHS<br />

expects of them – rights, pledges, duties <strong>and</strong><br />

expectations?<br />

Yes<br />

Individual Approval<br />

If you are happy to approve this document, please sign <strong>and</strong> date it <strong>and</strong> attach it to the policy document in<br />

preparation for committee approval.<br />

Name<br />

Signature<br />

Committee Approval<br />

If the Policy Sub-Committee is happy to approve this document, please sign <strong>and</strong> date it <strong>and</strong> forward copies to<br />

the person with responsibility for disseminating <strong>and</strong> implementing the document <strong>and</strong> the person who is<br />

responsible for uploading to the <strong>PCT</strong>’s library of corporate documents.<br />

Name<br />

Signature<br />

Date<br />

Date<br />

Acknowledgement: Cambridgeshire <strong>and</strong> Peterborough Mental Health Partnership NHS Trust<br />

Page 15 of 15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!